Advertisement
Screener

OrthoPediatrics Corp (KIDS) Overview

OrthoPediatrics Corp (KIDS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.30; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.45; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.50; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.30; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$13.91$16.56$19.72$23.48$27.97$33.302025-11-062026-11-06$13.91$19.46$27.23$38.11$53.32$74.612021-11-082026-11-06$13.80$19.45$27.39$38.59$54.36$76.582017-10-132026-11-06$13.80$19.45$27.39$38.59$54.36$76.582017-10-132026-11-06$13.80$19.45$27.39$38.59$54.36$76.582017-10-132026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$31.71
Previous close
$22.76
Change
$8.95
Change (%)
39.35%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

KIDS
+28.15%
S&P 500
(m)

1 year

KIDS
+24.30%
S&P 500
(m)

3 years

KIDS
-28.87%
S&P 500
(m)

5 years

KIDS
-65.09%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.30

-0.58-0.46-0.35-0.23-0.1231 Mar 2025: estimate (m); actual -0.4631 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.3030 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.5030 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.4531 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.3030 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.30(m)(m)
1 Jan 202631 Mar 2026(m)-0.45(m)(m)
1 Jul 202530 Sept 2025(m)-0.50(m)(m)
1 Apr 202530 Jun 2025(m)-0.30(m)(m)
1 Jan 202531 Mar 2025(m)-0.46(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.69

-1.77-1.27-0.77-0.260.2431 Dec 2021: estimate (m); actual -0.8431 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.0631 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.9231 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.6431 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.6931 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.69(m)(m)
1 Jan 202431 Dec 2024(m)-1.64(m)(m)
1 Jan 202331 Dec 2023(m)-0.92(m)(m)
1 Jan 202231 Dec 2022(m)0.06(m)(m)
1 Jan 202131 Dec 2021(m)-0.84(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 70.51M ■ Earnings -7.16M — Profit margin -10.16%

-21.65M-20.2%12.36M-16.5%46.37M-12.8%80.38M-9.2%30 Sept 2025: revenue 61.25M; earnings -11.77M; profit margin -19.22%30 Sept 202531 Dec 2025: revenue 61.60M*; earnings -10.10M*; profit margin -16.40%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 59.36M; earnings -10.69M; profit margin -18.00%31 Mar 202630 Jun 2026: revenue 70.51M; earnings -7.16M; profit margin -10.16%30 Jun 2026

31 Dec 2025 ■ Revenue 236.35M ■ Earnings -39.65M — Profit margin -16.78%

-72.77M-19.5%41.31M-12.3%155.39M-5.1%269.47M2.0%31 Dec 2022: revenue 122.29M; earnings 1.26M; profit margin 1.03%31 Dec 202231 Dec 2023: revenue 148.73M; earnings -20.97M; profit margin -14.10%31 Dec 202331 Dec 2024: revenue 204.73M; earnings -37.82M; profit margin -18.47%31 Dec 202431 Dec 2025: revenue 236.35M; earnings -39.65M; profit margin -16.78%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$31.71(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$31.71High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning KIDS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Index membership
(m)
Employees
602.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
180.71K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.00%*
Total return · month
-3.76%*
Total return · quarter
13.35%*
Total return · half year
46.65%*
Total return · year to date
28.15%*
Total return · 1 year
24.30%*
Total return · 3 years
-28.87%*
Total return · 5 years
-65.09%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

OrthoPediatrics Corp Overview

View more →

(m)

(m)

SEC CIK
1425450
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
2850 FRONTIER DRIVE, WARSAW, Indiana, 46582, United States
Fiscal year end
1231
Phone
574-268-6379

Similar stocks

Stock NameCountryMarket CapPE Ratio
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
CARLSMED, INC. (CARL)United States$0.405B